SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMMUNE NETWORK RESEARCH (VSE:IMM)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ralfph who wrote (129)11/25/2000 3:45:26 PM
From: .Trev  Read Replies (1) of 134
 
<"Immune Network Ltd - In the News
Van Sun says Immune Network in major HIV deal

Immune Network Ltd IMM
Shares issued 33,114,792 Nov 22 close $0.29
Thu 23 Nov 2000 In the News
The Vancouver Sun reports in its Thursday edition that Immune Network says
it has acquired an "exclusive" licence from a "major" Japanese company for
a new drug candidate to treat HIV infection. Reporter Rod Nutt notes that
the agreement is with Nissin Food Products of Osaka. The antibody, hNMO1,
was first discovered and patented by Nissin's research and development team
at the Nissin Biotechnology Institute in Boston, Mass. The drug candidate
is believed to act by inactivating the HIV virus, which may delay the full
development of AIDS in HIV infected individuals. "Immune Network's approach
to immune-based therapies for HIV, developing multiple agents with varying
mechanisms of action, has great potential for strengthening current
approaches to the treatment of HIV infection," says Dr. Brian Conway, a
"leading physician" in the field of HIV virology and a member of Immune
Network's advisory board. "As such, hNMO1 is an ideal candidate for further
evaluation in clinical trials," he says.
(c) Copyright 2000 Canjex Publishing Ltd. stockwatch.com ">

iGUESS THIS IS WHAT YOU'RE TALKING ABOUT???????
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext